This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
Should You Buy AppFolio (APPF) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
APPFPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
F.N.B. (FNB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
FNBNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Amgen (AMGN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
AMGNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Pagaya vs. OneMain: Which Consumer Credit Stock is a Smarter Bet?
by Nikita Kataruka
PGY leans on AI and asset-light growth, while OMF bets on brick-and-mortar lending and shareholder returns. Which stock deserves a place in your portfolio?
OMFNegative Net Change PGYNegative Net Change
banking fin-tech
Solid Transaction-Based Revenues to Drive HOOD's Q2 Earnings
by Zacks Equity Research
Robinhood's Q2 earnings are likely to have improved as trading volumes, crypto momentum and equity rise to fuel revenue growth.
SCHWPositive Net Change IBKRPositive Net Change HOODPositive Net Change
earnings fin-tech finance
Top Founder-Run Company Stocks That Are Outperforming the Market
by Tanuka De
Meta, Netflix, Robinhood Markets and DoorDash stand out as founder-run companies with strong vision, innovation, and long-term growth drivers.
NFLXPositive Net Change DASHPositive Net Change METAPositive Net Change HOODPositive Net Change
consumer-discretionary cryptocurrency fin-tech internet
PayPal Q2 Earnings Preview: Should You Buy the Stock Now or Wait?
by Moumita C. Chattopadhyay
PayPal targets Q2 EPS of up to $1.31, with higher TPV and active accounts fueling modest revenue and margin growth.
PYPLNegative Net Change MAPositive Net Change VPositive Net Change
earnings-preview fin-tech
Should You Buy Alphabet Inc. (GOOG) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
GOOGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should Robinhood Shares Be in Your Portfolio Pre-Q2 Earnings?
by Swayta Shah
HOOD eyes strong Q2 growth with soaring trading revenues and user gains, but regulatory risks still loom large. Is the stock a buy ahead of Q2 earnings?
SCHWPositive Net Change IBKRPositive Net Change HOODPositive Net Change
earnings-preview fin-tech finance
Coinbase vs. Circle: Which Stablecoin Powerhouse Is a Safer Bet?
by Tanuka De
COIN's broader revenue streams and strategic U.S. focus may offer steadier returns than CRCL's stablecoin-centric model.
COINPositive Net Change CRCLPositive Net Change
cryptocurrency fin-tech finance
3 Momentum Anomaly Picks as Markets Hit Record High on the Trot
by Supriyo Bose
NFLX, HOOD and AFRM made the momentum cut with strong 1-year gains and brief pullbacks, flashing a potential entry point.
NFLXPositive Net Change AFRMNegative Net Change HOODPositive Net Change
artificial-intelligence consumer-discretionary fin-tech finance internet-content tech-stocks
Raymond James Financial, Inc. (RJF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
RJFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
CryoPort, Inc. (CYRX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CYRXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Alphabet (GOOGL) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
GOOGLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Ur Energy (URG) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
URGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Envista (NVST)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
NVSTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Robinhood's Lofy Valuation: A Vote of Confidence or Cautionary Tale?
by Swayta Shah
HOOD trades at a steep premium. Can bold global moves, crypto growth and diversification justify the price? Let's have a look.
SCHWPositive Net Change IBKRPositive Net Change HOODPositive Net Change
fin-tech finance
How's MELI Using Argentina's Economic Recovery to Fuel its Growth?
by Zacks Equity Research
MercadoLibre rides Argentina's economic rebound with booming revenues, cross-border expansion, and bold fintech ambitions.
AMZNPositive Net Change MELINegative Net Change DLONegative Net Change
fin-tech retail
SoFi is Playing to Win and Not Backing Down From the Fintech Fight
by Zacks Equity Research
SOFI's net income surges 217% as it doubles down on innovation, partnerships, and fee-based growth amid fierce fintech rivalry.
UPSTPositive Net Change SOFIPositive Net Change XYZPositive Net Change
fin-tech finance
Can StoneCo's Software Divestment Unlock MSMB-Focused Growth?
by Moumita C. Chattopadhyay
StoneCo's sale of major software assets sharpens its MSMB focus as bundling, PIX and deposits drive momentum.
STNENegative Net Change MELINegative Net Change PAGSNegative Net Change
artificial-intelligence fin-tech
Mastercard vs. PayPal: Which Payments Innovator is the Better Buy Now?
by Kaibalya Pravo Dey
PayPal's lower valuation, direct commerce and lower leverage could make it the better buy over Mastercard now.
MAPositive Net Change PYPLNegative Net Change
business-services fin-tech finance payments
PayPal Taps New Markets: Will Interoperability Fuel Its Growth?
by Moumita C. Chattopadhyay
PYPL's new global platform links nearly 2B users and wallets, aiming to redefine cross-border commerce and payments.
PYPLNegative Net Change VPositive Net Change GPNNegative Net Change
artificial-intelligence fin-tech
Coherent (COHR) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
COHRPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Preferred Bank (PFBC)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PFBCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
BILL vs. Intuit: Which Fintech Powerhouse Stock Is the Smarter Buy?
by Nilanshi Mukherjee
INTU surges ahead with strong earnings and an expanding SMB ecosystem, while BILL Holdings battles headwinds despite innovation gains.
INTUNegative Net Change BILLNegative Net Change
artificial-intelligence automation fin-tech tech-stocks